AngioDynamics (ANGO) Stock Chart & Stock Price History → On June 10, Nvidia makes its next big move (From Weiss Ratings) (Ad) Free ANGO Stock Alerts $6.31 +0.04 (+0.64%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends AngioDynamics Stock Price Performance5 Day Performance+2.27%1 Month Performance+8.98%3 Month Performance+14.73%6 Month Performance-8.02%Year-To-Date Performance-19.52%1 Year Performance-34.54% Receive ANGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. ANGO Stock Chart for Saturday, June, 1, 2024 ANGO Chart by TradingView AngioDynamics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$6.27$6.31+0.64%$6.43$6.26316,397 shs$252.78 million05/30/2024$6.13$6.27+2.28%$6.28$6.07355,123 shs$251.18 million05/29/2024$6.24$6.13-1.76%$6.30$6.11273,504 shs$245.57 million05/28/2024$6.17$6.24+1.13%$6.27$6.03329,253 shs$249.97 million05/27/2024$6.17$6.17$6.27$6.06214,100 shs$247.17 million05/24/2024$6.12$6.17+0.82%$6.19$6.06214,155 shs$247.17 million Get the Latest News and Ratings for ANGO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$6.32$6.12-3.16%$6.37$6.04469,774 shs$245.17 million05/22/2024$5.86$6.32+7.85%$6.41$5.75697,602 shs$253.18 million05/21/2024$5.81$5.86+0.86%$5.94$5.72539,316 shs$234.75 million05/20/2024$6.04$5.81-3.81%$6.14$5.80348,511 shs$232.75 million05/17/2024$6.42$6.04-5.92%$6.58$6.04310,290 shs$241.96 million05/16/2024$6.36$6.42+0.94%$6.42$6.29279,202 shs$257.19 million05/15/2024$6.17$6.36+3.08%$6.41$6.17323,100 shs$254.78 million05/14/2024$6.12$6.17+0.82%$6.27$6.12373,107 shs$247.17 million05/13/2024$6.05$6.12+1.16%$6.24$6.03310,887 shs$245.17 million05/10/2024$6.12$6.05-1.14%$6.25$5.93424,067 shs$242.33 million05/09/2024$5.89$6.12+3.90%$6.12$5.85394,945 shs$245.14 million05/08/2024$6.14$5.89-4.07%$6.11$5.84437,388 shs$235.92 million05/07/2024$6.20$6.14-0.97%$6.26$6.12278,859 shs$245.97 million05/06/2024$6.27$6.20-1.12%$6.40$6.16471,994 shs$248.37 million05/03/2024$6.08$6.27+3.12%$6.27$6.07307,439 shs$251.18 million05/02/2024$5.79$6.08+5.01%$6.29$6.06654,702 shs$243.57 million05/01/2024$5.79$5.79$5.98$5.71357,073 shs$231.95 million04/30/2024$5.82$5.79-0.52%$5.86$5.66261,710 shs$231.95 million04/29/2024$5.81$5.82+0.17%$5.97$5.81288,312 shs$233.15 million04/26/2024$5.78$5.81+0.52%$6.44$5.76313,347 shs$232.75 million04/25/2024$5.87$5.78-1.53%$5.85$5.72373,060 shs$231.55 million04/24/2024$6.03$5.87-2.65%$6.02$5.83586,457 shs$235.15 million04/23/2024$6.26$6.03-3.67%$6.30$6.00379,009 shs$241.56 million04/22/2024$6.26$6.26$6.37$6.19336,227 shs$250.78 million04/19/2024$6.12$6.26+2.29%$6.27$6.06479,291 shs$250.78 million04/18/2024$6.33$6.12-3.32%$6.38$6.11806,883 shs$245.17 million04/17/2024$6.51$6.33-2.76%$6.52$6.30490,691 shs$253.58 million04/16/2024$6.31$6.51+3.17%$6.56$6.23514,506 shs$260.79 million04/15/2024$6.37$6.31-0.94%$6.41$6.26596,541 shs$252.78 million04/12/2024$6.80$6.37-6.32%$6.90$6.32608,508 shs$255.18 million04/11/2024$6.85$6.80-0.73%$7.03$6.79761,556 shs$270.98 million04/10/2024$6.97$6.85-1.72%$7.06$6.77634,212 shs$272.97 million04/09/2024$6.61$6.97+5.45%$7.17$6.841.30 million shs$277.79 million04/08/2024$7.03$6.61-5.97%$7.19$6.601.22 million shs$263.41 millionThe ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now.04/05/2024$6.40$7.03+9.84%$7.52$6.792.15 million shs$280.15 million04/04/2024$6.08$6.40+5.26%$7.20$6.351.38 million shs$255.04 million04/03/2024$6.19$6.08-1.78%$6.37$6.07858,282 shs$242.29 million04/02/2024$5.83$6.19+6.17%$6.30$5.97914,155 shs$246.67 million04/01/2024$5.87$5.83-0.68%$6.05$5.76460,153 shs$232.33 million03/29/2024$5.87$5.87$5.90$5.73428,809 shs$233.95 million03/28/2024$5.70$5.87+2.98%$5.90$5.73428,809 shs$233.92 million03/27/2024$5.40$5.70+5.56%$5.71$5.45505,396 shs$227.15 million03/26/2024$5.27$5.40+2.47%$5.48$5.30381,691 shs$215.19 million03/25/2024$5.36$5.27-1.68%$5.49$5.26334,226 shs$210.01 million03/22/2024$5.52$5.36-2.90%$5.55$5.35269,051 shs$213.60 million03/21/2024$5.59$5.52-1.25%$5.72$5.51336,996 shs$219.97 million03/20/2024$5.55$5.59+0.72%$5.66$5.50289,971 shs$222.76 million03/19/2024$5.39$5.55+2.97%$5.61$5.31276,489 shs$221.17 million03/18/2024$5.37$5.39+0.37%$5.54$5.27450,803 shs$214.79 million03/15/2024$5.41$5.37-0.74%$5.47$5.36684,511 shs$213.99 million03/14/2024$5.56$5.41-2.70%$5.63$5.37419,012 shs$215.59 million03/13/2024$5.49$5.56+1.28%$5.62$5.45300,370 shs$221.57 million03/12/2024$5.47$5.49+0.37%$5.53$5.35385,671 shs$218.78 million03/11/2024$5.67$5.47-3.53%$5.69$5.43340,883 shs$217.98 million03/08/2024$5.75$5.67-1.39%$5.88$5.66333,159 shs$225.95 million03/07/2024$5.57$5.75+3.23%$5.80$5.59332,692 shs$229.14 million03/06/2024$5.62$5.57-0.89%$5.90$5.51489,437 shs$221.96 million03/05/2024$5.54$5.62+1.44%$5.75$5.55361,508 shs$220.80 million03/04/2024$5.50$5.54+0.73%$5.69$5.38771,978 shs$220.77 million03/01/2024$5.49$5.50+0.18%$5.56$5.26660,475 shs$219.18 million02/29/2024$5.73$5.49-4.19%$5.86$5.49548,487 shs$218.78 million Related Companies: Cytosorbents Stock Chart Orthofix Medical Stock Chart Surmodics Stock Chart Accuray Stock Chart Rockwell Medical Stock Chart ReShape Lifesciences Stock Chart Abbott Laboratories Stock Chart Intuitive Surgical Stock Chart Stryker Stock Chart Boston Scientific Stock Chart Receive ANGO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANGO) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.